Abstract
Ajuga bracteosa is a valuable medical plant producing many important compounds. including with anolides, phytoecdysteroids, neo-clerodane-di and triterpenes, iridoid glycosides, flavonoids, etc. These compounds possess a broad spectrum of biological, pharmacological and medicinal properties, but their yield is very low in wild-type plants, and chemical synthesis is not viable. Metabolic engineering strategies offer a promising solution for the bulk production of these natural products. However, these strategies usually require the establishment of an efficient genetic transformation method, which to date has not been reported for A. bracteosa. Therefore, the current study was conducted by employing Agrobacterium tumefaciens C58C1 harboring the binary plasmid p35SGUSint with GUS as the reporter geneand the NTPII gene as the selectable marker. The influential factors, e. g. explant type, optical density of agrobacterial culture, inoculation period, co-cultivation duration and acetosyringone concentration, were systematically investigated and the optimal transformation conditions were established by 72 independent transformation experiments. Putative transformants were selected on kanamycin 100mg/L. MS medium supplemented with 3.6mg/L BA resulted in maximum regeneration frequency of the transformed explants. The expression of the GUS gene was confirmed by histochemistry and polymerase chain reaction. We established that nodal explants of A. bracteosa precultured for 3 days, inoculated witha culture of A. tumefaciens with an OD of 1.0 for 20 min and co-cultivated for 2 days in MS medium with 200 mu M acetosyringone at media pH 5.8 showed 100% transformation induction. This is the first report of a successful A. tumefaciens-mediated transformation of A. bracteosa. (C) 2016 Elsevier GmbH. All rights reserved.